David H Henry

4PUBLICATIONS
3CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 17, 2024
Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial.

Moshe Mittelman, David H Henry, John A Glaspy

|Jan 30, 2023
Open-label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies.

John Glaspy, Nashat Y Gabrail, Patricia Locantore-Ford

|Apr 05, 2022
Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma.

David H Henry, Robert G Maki

|Nov 01, 2021
Roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic syndrome: Open-label, dose-selection, lead-in stage of a phase 3 study.

David H Henry, John Glaspy, Rosemary Harrup

Pageof 1

Frequent Collaborators

3 joint publications

John Glaspy

2 joint publications

Moshe Mittelman

1 joint publications

Robert G Maki